In the endometrial and ovarian cancer cell lines ECC-1 and HCH-1, respectively, FCF decreases the expression of HER2 (human epidermal growth factor receptor 2; human gene symbol: ERBB2), a protein which is often overexpressed in certain tumor types. Here, ERBB2 is linked to neoplasm.